GLP-1 drugs such as semaglutide and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights the urgent need for nutrition, hydration and resistance training alongside medication
firstpost.com
firstpost.com
